胺及其对抑郁症的反体:从2000年到2023年的图书统计分析
Li-Yuan Zhao1, Guang-Fen Zhang2, Xue-Jie Lou1
1Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
European archives of psychiatry and clinical neuroscience
|April 25, 2024
概括
胺显示出快速的抗抑郁作用,推动对其有效性,安全性和机制的研究. 这种图书统计分析绘制了越来越多的关于胺及其对抑郁症治疗的反体的文献.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 图书统计学 图书统计学
背景情况:
- 胺具有快速和持续的抗抑郁作用,将其定位为一种创新的抑郁症治疗方法.
- 目前还没有对胺胺抗抑郁药的研究进行全面的文献分析.
研究的目的:
- 进行关于胺和其反体的抗抑郁作用的文献图书统计分析.
- 确定该领域的关键研究主题和趋势.
主要方法:
- 从2000年至2023年的出版物从科学网络核心集合 (WOSCC) 中获取.
- 他们使用了图书统计分析和可视化工具 (VOSviewer,CiteSpace,R包"bibliometrix").
- 使用并发分析来确定研究焦点.
主要成果:
- 总共分析了4,274篇出版物,研究成果显著增加,到2022年达到顶峰.
- 两个主要的研究领域出现了:胺对抑郁症的疗效/安全性及其抗抑郁机制.
- 研究的增长与治疗耐药性抑郁症的埃斯基坦胺鼻喷雾的批准有关.
结论:
- 在过去的二十年中,对胺的抗抑郁作用的研究急剧增加.
- 胺素的快速抗抑郁作用刺激了对其机制的进一步研究.
- 这种研究环境推动了对具有改善副作用概况的新型抗抑郁药物的搜索.
相关概念视频
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
01:25Antidepressant Drugs: Overview
459
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
459
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:03Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
01:30Electroconvulsive Therapy
37
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
37